Annie Im

1.7k total citations
64 papers, 851 citations indexed

About

Annie Im is a scholar working on Hematology, Oncology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Annie Im has authored 64 papers receiving a total of 851 indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Hematology, 19 papers in Oncology and 13 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Annie Im's work include Hematopoietic Stem Cell Transplantation (30 papers), Acute Myeloid Leukemia Research (24 papers) and Childhood Cancer Survivors' Quality of Life (9 papers). Annie Im is often cited by papers focused on Hematopoietic Stem Cell Transplantation (30 papers), Acute Myeloid Leukemia Research (24 papers) and Childhood Cancer Survivors' Quality of Life (9 papers). Annie Im collaborates with scholars based in United States, Canada and Croatia. Annie Im's co-authors include Steven Z. Pavletic, Michael Boyiadzis, Alison R. Sehgal, Daniel E. Johnson, Ayalew Tefferi, Martin Carroll, B. Douglas Smith, Anastasios Raptis, Mounzer Agha and Kathleen Dorritie and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Annie Im

58 papers receiving 837 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Annie Im United States 13 403 301 242 231 139 64 851
Valérie Mialou France 12 407 1.0× 191 0.6× 228 0.9× 190 0.8× 113 0.8× 45 912
Ivetta Danylesko Israel 17 495 1.2× 299 1.0× 149 0.6× 124 0.5× 114 0.8× 67 842
Vanessa E. Kennedy United States 15 277 0.7× 232 0.8× 177 0.7× 208 0.9× 73 0.5× 45 843
C. Michel Zwaan Netherlands 18 313 0.8× 280 0.9× 293 1.2× 117 0.5× 147 1.1× 74 943
Catherine Paillard France 19 390 1.0× 237 0.8× 129 0.5× 243 1.1× 150 1.1× 68 973
Paul Cannell Australia 18 519 1.3× 373 1.2× 229 0.9× 183 0.8× 251 1.8× 55 1.1k
Asmita Mishra United States 15 411 1.0× 234 0.8× 187 0.8× 72 0.3× 123 0.9× 63 672
Yeo‐Kyeoung Kim South Korea 20 675 1.7× 261 0.9× 412 1.7× 243 1.1× 253 1.8× 91 1.2k
Saskia K. Klein Netherlands 14 434 1.1× 224 0.7× 248 1.0× 113 0.5× 130 0.9× 43 919
Yunsuk Choi South Korea 18 480 1.2× 444 1.5× 339 1.4× 136 0.6× 178 1.3× 101 1.1k

Countries citing papers authored by Annie Im

Since Specialization
Citations

This map shows the geographic impact of Annie Im's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Annie Im with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Annie Im more than expected).

Fields of papers citing papers by Annie Im

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Annie Im. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Annie Im. The network helps show where Annie Im may publish in the future.

Co-authorship network of co-authors of Annie Im

This figure shows the co-authorship network connecting the top 25 collaborators of Annie Im. A scholar is included among the top collaborators of Annie Im based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Annie Im. Annie Im is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mehta, Rohtesh S., Hannah Choe, Jennifer N. Saultz, et al.. (2025). Impact of Donor Age and Donor Cytomegalovirus Serostatus on Outcomes After Related Donor Allogeneic Hematopoietic Stem Cell Transplantation. American Journal of Hematology. 100(6). 987–997.
2.
Patell, Rushad, Poorva Bindal, Jason A. Freed, et al.. (2025). A Multicenter Feasibility Study of a Novel Curriculum for Oncology Trainees Regarding Medical Cannabis. Journal of the National Comprehensive Cancer Network. 23(3). 82–89.
3.
McManus, Taylor, Noa G. Holtzman, Susan Vitale, et al.. (2024). Systemic Treatment with the Janus Kinase Inhibitor Baricitinib in Ocular Chronic Graft-versus-Host Disease. SHILAP Revista de lepidopterología. 5(1). 100627–100627. 1 indexed citations
4.
Abaza, Yasmin, Eric S. Winer, Guru Subramanian Guru Murthy, et al.. (2024). Clinical outcomes of hypomethylating agents plus Venetoclax as frontline treatment in patients 75 years and older with acute myeloid leukemia: Real‐world data from eight US academic centers. American Journal of Hematology. 99(4). 606–614. 12 indexed citations
5.
Iasella, Carlo J., Iulia Popescu, Robin Burke, et al.. (2023). Lung transplant recipients with telomere-mediated pulmonary fibrosis have increased risk for hematologic complications. American Journal of Transplantation. 23(10). 1590–1602. 9 indexed citations
6.
Im, Annie, et al.. (2023). Treatment of Acute Myeloid Leukemia in Older Adults. Cancers. 15(22). 5409–5409. 5 indexed citations
7.
Holtzman, Noa G., Annie Im, Arlene Berman, et al.. (2023). Baricitinib for Refractory Chronic Graft-Versus-Host Disease (cGVHD): Results of a Phase 1/2 Study. Transplantation and Cellular Therapy. 29(2). S251–S252. 1 indexed citations
8.
Jain, Tania, Tristan Knight, Laurie Davis, et al.. (2022). American Society for Transplantation and Cellular Therapy Guidelines for Fellowship Training in Hematopoietic Cell Transplantation and Immune Effector Cell Therapy. Transplantation and Cellular Therapy. 28(3). 125–133. 3 indexed citations
9.
10.
Posluszny, Donna M., Dana H. Bovbjerg, Karen L. Syrjala, et al.. (2021). Rates and Predictors of Nonadherence to the Post-Allogeneic Hematopoietic Cell Transplantation Medical Regimen in Patients and Caregivers. Transplantation and Cellular Therapy. 28(3). 165.e1–165.e9. 10 indexed citations
11.
Resick, Judith, Robert M. Arnold, Thomas W. LeBlanc, et al.. (2020). Primary Palliative Care for Patients with Advanced Hematologic Malignancies: A Pilot Trial of the SHARE Intervention. Journal of Palliative Medicine. 24(6). 820–829. 11 indexed citations
12.
13.
Im, Annie, Rodica Morariu-Zamfir, Maureen R. Bleam, Ying Yan, & Steven Z. Pavletic. (2019). Trial in Progress: A Phase 3 Study of Itacitinib or Placebo in Combination with Corticosteroids As Initial Treatment for Chronic Graft-Versus-Host Disease (GRAVITAS-309). Blood. 134(Supplement_1). 3277–3277. 5 indexed citations
14.
Redner, Robert L., Jan H. Beumer, Patricia Kropf, et al.. (2018). A phase-1 study of dasatinib plus all-trans retinoic acid in acute myeloid leukemia. Leukemia & lymphoma. 59(11). 2595–2601. 10 indexed citations
15.
Steinberg, Seth M., Sri Harsha Tella, Jennifer L. Hsu, et al.. (2016). Characterization and Risk Factor Analysis of Osteoporosis in a Large Cohort of Patients with Chronic Graft-versus-Host Disease. Biology of Blood and Marrow Transplantation. 22(8). 1517–1524. 11 indexed citations
16.
Roth, Christine G., David R. Weber, Alison R. Sehgal, et al.. (2016). ICU intervention during induction chemotherapy for adult patients with newly diagnosed acute myeloid leukemia. Leukemia Research. 48. 16–19. 1 indexed citations
17.
Raptis, Anastasios, Jing‐Zhou Hou, Rafic Farah, et al.. (2015). Outcome of acute myeloid leukemia patients with pulmonary nodules of uncertain etiology receiving allogeneic hematopoietic progenitor cell transplant. European Journal Of Haematology. 96(1). 55–59. 1 indexed citations
18.
Im, Annie, Alison R. Sehgal, Martin Carroll, et al.. (2014). DNMT3A and IDH mutations in acute myeloid leukemia and other myeloid malignancies: associations with prognosis and potential treatment strategies. Leukemia. 28(9). 1774–1783. 193 indexed citations
19.
Taioli, Emanuela, Annie Im, Xia Xu, et al.. (2010). Comparison of estrogens and estrogen metabolites in human breast tissue and urine. Reproductive Biology and Endocrinology. 8(1). 93–93. 19 indexed citations
20.
Im, Annie & Leonard J. Appleman. (2010). Mifepristone: pharmacology and clinical impact in reproductive medicine, endocrinology and oncology. Expert Opinion on Pharmacotherapy. 11(3). 481–488. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Valérie Mialou Breakdown of academic impact, for papers by Ivetta Danylesko Breakdown of academic impact, for papers by Vanessa E. Kennedy Breakdown of academic impact, for papers by C. Michel Zwaan Breakdown of academic impact, for papers by Catherine Paillard Breakdown of academic impact, for papers by Paul Cannell Breakdown of academic impact, for papers by Asmita Mishra Breakdown of academic impact, for papers by Yeo‐Kyeoung Kim Breakdown of academic impact, for papers by Saskia K. Klein Breakdown of academic impact, for papers by Yunsuk Choi
Rankless by CCL
2026